Soleus Capital Management’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,424,000
Closed -$11.6M 89
2024
Q3
$11.6M Buy
1,424,000
+218,000
+18% +$1.44M 0.9% 37
2024
Q2
$8.41M Buy
1,206,000
+536,000
+80% +$4.06M 0.74% 44
2024
Q1
$7.11M Buy
+670,000
New +$5.86M 0.53% 54
2023
Q4
Sell
-1,408,801
Closed -$11.6M 79
2023
Q3
$11.6M Buy
1,408,801
+253,301
+22% +$2.18M 1.07% 32
2023
Q2
$9.24M Buy
+1,155,500
New +$8.52M 1.03% 30

Other funds holding BHC

Soleus Capital Management's BHC Position: Q4 2024 in Review

Soleus Capital Management sold out of Bausch Health (BHC) in Q4 2024, closing a stake of 1,424,000 shares — an estimated $11.6M sold.

Soleus Capital Management first reported a position in BHC in Q2 2023 and held it in 5 quarters. The position peaked at $11.6M in Q3 2024. 225 funds tracked by Wall St. Rank hold BHC as of Q4 2024.

  • Soleus Capital Management reported no remaining Bausch Health position as of Q4 2024 after selling out during the quarter.
  • Soleus Capital Management sold 1,424,000 Bausch Health shares in Q4 2024, an estimated $11.6M.
  • Soleus Capital Management first reported a position in Bausch Health in Q2 2023 and held it in 5 quarters.
  • Soleus Capital Management's Bausch Health position peaked at $11.6M in Q3 2024.
  • 225 funds tracked by Wall St. Rank held Bausch Health as of Q4 2024.

Based on Soleus Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.